They used a PRMT5 inhibitor to determine the importance of repressive epigenetic marks in context of EBV tumors and concluded that PRMT5 was critical for B cell transformation and malignancies because the overexpression of PRMT5 helped to silence the tumor suppressor genes [74]. This evidence concerns the gene PRMT5 and neoplasm.